Skip to main content
. 2002 Apr 27;324(7344):1012. doi: 10.1136/bmj.324.7344.1012

Table 6.

Main events counted to estimate use of resources over the one year follow up

Eradication group (No of events) Eradication costs ($C) Placebo group (No of events) Placebo costs ($C)
Admissions to hospital for stomach problems  1   432  6 2 592
Visits to family practitioner 120 2 186 150 2 787
Visits to specialist (surgeon or gastroenterologist) 24 1 631 32 2 033
Upper gastrointestinal barium study 13 1 103 14 1 188
Upper gastrointestinal endoscopy 11 1 041 16 1 514
Cost of prescription drugs for dyspepsia* 179 prescriptions (73 patients) 25 816 299 prescriptions (87 patients) 38 974
Cost of non-prescription drugs for dyspepsia 3 527 4 486
Laboratory tests 24   714 36 1 254
Days of work missed 263 (30 patients) 16 910 226 (24 patients) 13 200
Other 53 2 138 61 2 663

1 $C≈0.60 US$≈£0.43. 

*

Costs include drug treatment at start of study; costs taken from a log of gastrointestinal medications; includes antibiotics given for repeat Helicobacter pylori eradication treatment during the study. 

Cost of non-prescription drugs paid by the patient as reported in the questionnaire; the number and types of drugs taken were not captured. 

Includes visits to a nurse, imaging studies (abdominal and chest radiography, ultrasonography of abdomen and pelvis, computed tomography of abdomen, barium enema), sigmoidoscopy, one colonoscopy, and transportation costs.